Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

biOasis Technologies Ord Shs V.BTI.H

Alternate Symbol(s):  BIOAF

Healthcare Biotechnology
Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.


TSXV:BTI.H - Post by User

biOasis Technologies Ord Shs > question for MBT123
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(286)
•••
Comment by beenthereon May 11, 2021 8:59pm
169 Views
Post# 33180045

RE:RE:RE:RE:RE:RE:RE:question for MBT123

RE:RE:RE:RE:RE:RE:RE:question for MBT123Chrispi, why to you think you are right all the time?
Why do you think that what MPT says is a lie?
You don't even have a clue who he is or what goes on his life.

For what it's worth I agree with what he says and probably match him quite closely.

I bad mouth BTI and I have no worries that I am affecting my investment!

Why?

Well for starters the most important thing is this is "just" a bull board and anyone who bases their investment on what is said on a bull board is an idiot!

I have not ever got any respect on this bb mainly because it is populated with JD lovers who are blind to anything other than what he says! (And how has that worked out for you?)
SO it doesn't matter what my opinion is about BTI it's never going to affect anyone's opinion about BTI right?

I have been here for 10 years and hold 217 800 shares ( and yes chrispi I don't give a sh*t if you believe me or not ... it's not going to bring my money back) . I hold BTI in 4 accounts between my wife and myself. Only one I have to worry about tax implications so I am not sure what my total investment has been but it's in excess of $ 200 000.

So yes I am super frustrated with this investment?  so please excuse me for feeling the way I do but guess what? I am human!
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities